Nuclear Pharmacy Market to Grow Along with Increasing Tourism During the Forecast Period
Increasing demand for nuclear medicine is driving the
growth in Global Nuclear Pharmacy Market in the forecast period, 2022-2026.
According to TechSci Research report, “Nuclear
Pharmacy Market - Global Industry Size, Share, Trends, Opportunity and
Forecast, 2016-2026”, the global nuclear pharmacy market has a
potential to project an impressive CAGR toward forces growth in the period,
2022-2026, on the account of increasing instances of cancer. Also, conventional
chemotherapy methods are being taken over by more convenient
radiopharmaceutical and driving the growth of the global nuclear pharmacy
market in the upcoming five years.
Increasing utilization of radio pharmaceutical is also supporting the
growth of the global nuclear pharmacy market in the next five years.
Additionally, advancement in the nuclear medicine and their storage conditions
along with possible distribution channel advances substantiate the growth of
the global nuclear pharmacy market in the future five years.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Nuclear Pharmacy Market"
https://www.techsciresearch.com/report/nuclear-pharmacy-market/8136.html
The global nuclear pharmacy market is segmented on the basis of type,
purpose, competitional landscape, and regional distribution. Based on type, the
market is further fragmented into institutional, and commercial. Institutional
nuclear pharmacy is anticipated to register largest revenue shares of the
market and dominate the market segment in the upcoming five years on the
account of increasing instances of cancer.
Also, radio pharmacy numbers are increasing with the hospital dependency
and thus supporting the growth of the global nuclear pharmacy market in the
next five years. Also, increasing number of patients over burdens the hospitals
and attached institutional nuclear pharmacy relives that over burdening on the
hospitals thus supporting the global nuclear pharmacy market growth in the
future five years.
Furthermore, commercial nuclear pharmacy is expected to register fastest
growing CAGR on the account of rising disposable income among the population.
The tendency of the patients over spending to avail expensive healthcare
facilities is further driving the growth of the sub-segment as well as aiding
the growth of the global nuclear pharmacy market in the forecast years.
On the basis of purpose, the market is bifurcated into diagnostic, and
therapeutic. Diagnostic purpose of the nuclear pharmacy is anticipated to
register the largest revenue shares of the market in the upcoming five years on
the grounds of increasing demands for the effective and early diagnosis of the
cancer diseases.
Identification of cancer is very difficult and often happens when the
disease has already matured. Late stage presentation and lack of access to the
early diagnosis presents threat to the larger population of the world.
Governments are taking solid initiatives and research institutes are
consistently trying to evolve their methods of diagnosis such that they support
the growth of the global nuclear pharmacy market in the upcoming five years.
Increasing demand for the effective treatment and ongoing research along
with the development of the technologically advanced therapies for cancer is
expected to support the significant growth of the therapeutic purpose of the
nuclear pharmacy meanwhile supporting the growth of the global nuclear pharmacy
market in the forecast period, until 2026.
Some of the global nuclear pharmacy market players, dominating the
global market are:
·
Jubilant Radiopharma (Jubilant Pharma Holdings
Inc.)
·
GE Healthcare
·
Cardinal Health, Inc.
·
ARTMS Inc.
·
AnazaoHealth Corp.
·
SOFIE
·
Pacific Radiopharmacy, Ltd.
These market players along
with new market entrants, are focused on extensive research and bringing
innovative and advanced nuclear pharmaceutical products and services.
Technologically advanced manufacturing of the nuclear medicine and their
storage and distribution channels would aid in decreasing the cost and aid the
players in managing their investments. Moreover, initiatives from the
government and private fundings would support the global nuclear pharmacy
market growth indirectly.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=8136
Customers can also request for
10% free customization on this report.
“North America is
anticipated to dominate the market region on the grounds of increasing number
of patients suffering from cancer. Moreover, increasing instances of breast
cancer, blood cancer, lung cancer, and liver cancer is increasing and demands
for the effective treatment is aiding the growth of the global nuclear pharmacy
market in the next five years. Also, well-established healthcare industry in
countries like the United States, Canada, are also supporting the growth of the
global nuclear pharmacy market in the upcoming five years. Consistent research
and technologically advanced nuclear medicines are further substantiating the
growth of the global nuclear pharmacy market in the future five years. Asia
Pacific region is further expected to register significant growth in the
upcoming five years owing to the budding research institutes and their
dedicated approaches toward cancer treatments is projected to support the
growth of the global nuclear pharmacy market in the region in forecast years,”
said Mr. Karan Chechi, Research Director with TechSci Research, a research
based global management consulting firm.
“Global Nuclear Pharmacy Market
- Global Industry Size, Share, Trends, Opportunity and Forecast, 2016-2026 Segmented By Type (Institutional v/s Commercial), By
Purpose (Diagnostic v/s Therapeutic), By Region”,
has evaluated the future growth potential of global nuclear pharmacy and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global nuclear pharmacy market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/